Terms: = Prostate cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Staging
2 results:
1. A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.
Maresca KP; Hillier SM; Femia FJ; Keith D; Barone C; Joyal JL; Zimmerman CN; Kozikowski AP; Barrett JA; Eckelman WC; Babich JW
J Med Chem; 2009 Jan; 52(2):347-57. PubMed ID: 19111054
[TBL] [Abstract] [Full Text] [Related]
2. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
[TBL] [Abstract] [Full Text] [Related]
